Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial

Ann Oncol 2017; 28: 128–135 (doi: 10.1093/annonc/mdw434)

from Cancer via ola Kala on Inoreader https://ift.tt/2r3dEpL
via IFTTT